Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 8,857 shares, a growth of 121.2% from the September 15th total of 4,004 shares. Based on an average trading volume of 46,829 shares, the short-interest ratio is presently 0.2 days.
Alpha Tau Medical Price Performance
Shares of NASDAQ DRTSW traded down $0.33 during midday trading on Thursday, hitting $3.29. 17,123 shares of the company’s stock traded hands, compared to its average volume of 58,642. The firm has a fifty day moving average of $3.90 and a 200 day moving average of $2.74. Alpha Tau Medical has a 1 year low of $0.27 and a 1 year high of $4.62.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is an Israeli medical-device company focused on developing cancer treatments based on targeted alpha radiation. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver localized alpha radiation directly into solid tumors while limiting exposure to surrounding healthy tissue.
Alpha DaRT uses implantable sources containing radium-224. As the material decays, it generates short-range alpha particles intended to damage tumor cells.
See Also
- Five stocks we like better than Alpha Tau Medical
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation
- Solaris Rides the AI Boom as Risks Mount
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
